|Starpharma Holdings Limited|
Baker IDI Building
75 Commercial Road
Australia - Map
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of its topical vaginal microbicide VivaGel as a condom coating for the treatment and prevention of bacterial vaginosis, as well as for the prevention of sexually transmitted infections, including genital herpes and HIV. It is also engaged in exploring dendrimer opportunities in materials science with applications in various areas, such as cosmetics, agrochemicals, and coatings. The company was founded in 1996 and is headquartered in Melbourne, Australia.
|Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA,
Chief Exec. Officer and Exec. Director
|Mr. Nigel J. Baade B.Com, CPA, Grad. Dip. Arts,
Chief Financial Officer and Company Sec.
|Dr. Jeremy R. Paull BSc (Hons), Ph.D.,
VP of Devel. & Regulatory Affairs
|Dr. C. Paul Barrett B.Sc. (Hons), Ph.D.,
VP of Bus. Devel.
|Dr. David J. Owen BSc(Hons) Ph.D.,
VP of Research
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in AUD.|